Filing Details

Accession Number:
0001209191-22-045321
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-10 20:21:15
Reporting Period:
2022-08-08
Accepted Time:
2022-08-10 20:21:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1286710 Francis Cano C/O Dynavax Technologies Corporation
2100 Powell Street, Suite 720
Emeryville CA 94608
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-08 15,000 $4.97 35,834 No 4 M Direct
Common Stock Disposition 2022-08-08 15,000 $17.17 20,834 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-08-08 15,000 $0.00 15,000 $4.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-05-29 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $17.16 to $17.20; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
  2. These options fully-vested on May 30, 2020, upon the one-year anniversary of the grant date.
  3. Not applicable.